Huang Min — Intellectual Property Lawyer in Hefei

Huang’s profile is particularly well matched to Hefei’s research-driven economy. The city has a concentration of universities, national laboratories, research institutes, semiconductor businesses, advanced manufacturing companies and technology platforms. His representative clients and projects include the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, the Hefei Comprehensive National Science Center Energy Research Institute, the University of Science and Technology of China’s advanced technology institute and other research and innovation organizations.

A recurring legal problem in this ecosystem is moving technology from a research institution into a commercial company. A patent may have been created as a service invention by researchers employed by an institute. Technical know-how may remain unpatented and protected as a trade secret. A spin-out company may need an exclusive license, assignment or contribution of IP. Investors then need to confirm that the company actually controls the technology on which its valuation depends.

Huang’s combination of IP litigation and technology-transfer work is valuable because commercialization structures should be designed with future disputes in mind. It is not enough to sign a broad agreement stating that the startup may “use the technology.” The parties should identify patents, applications, improvements, data, know-how, inventor rights, sublicensing, field restrictions and termination. If the spin-out later raises venture capital or seeks an IPO, ambiguity in those rights can become a material diligence problem.

His official profile also describes major technology-results commercialization projects for national-level research institutions. Technology-transfer work in this context may involve public-sector asset rules, valuation, approvals, licensing and corporate structuring in addition to ordinary IP law. The lawyer needs to understand both ownership and the institutional process required to dispose of or commercialize the technology.

Huang’s patent and trade-secret experience also matters because not all valuable technology should be patented. Patent filing requires disclosure. Certain manufacturing processes, algorithms or data may be more valuable as confidential know-how. A commercialization agreement should therefore distinguish registered IP from trade secrets and define how the spin-out will access, protect and improve each category.

His litigation experience provides another important perspective. If a former researcher, partner or competing company later challenges ownership, the spin-out needs evidence of development history, employment status, assignments, confidentiality measures and licensing. Those records are easier to create at commercialization than after a dispute begins.

Huang’s work with technology companies and major corporate clients also gives him relevance beyond research institutes. Technology commercialization may lead to financing, M&A, licensing, joint ventures or strategic investment. The legal structure should allow future investors to understand the company’s rights without reopening the entire relationship with the institute.

Technology commercialization also requires careful treatment of improvements. A research institute may license existing patents to a spin-out while continuing to conduct research in the same field. The startup may then develop improvements using institute facilities or joint research personnel. Unless the agreements define ownership, licensing and publication rights for those improvements, future investors can face uncertainty about whether the company controls the next generation of its own technology.

Huang’s work with research institutions makes him particularly relevant to this interface between public research and venture capital. The legal team must often coordinate institute approvals, valuation of technology, employee or inventor rights, confidentiality and the company’s financing documents. A venture investor may accept a license rather than ownership if the license is exclusive, long-term, transferable where needed and protected against arbitrary termination.

His litigation experience also matters because commercialization documents should be drafted with enforcement evidence in mind. If a researcher later claims personal ownership, or if the institute argues that a startup exceeded the licensed field, the parties will need development records, approval documents and precise definitions. A clean technology-transfer file can preserve enterprise value years later during a financing, acquisition or IPO.

Hefei’s role as a national science and technology center also means that commercialization work may involve several institutions in the same project: a research institute, university team, state-owned platform company, venture fund and operating startup. Counsel must define which entity owns each legal right and which agreements create access. That coordination is essential if the company later seeks institutional financing.

Huang’s work also fits companies preparing for institutional financing because technology ownership and commercialization rights are often among the first diligence questions raised by venture funds and strategic investors. His combination of research-institute work, IP disputes and corporate matters is relevant to turning a laboratory-originated technology package into rights that a company can explain clearly to outside capital providers.